2017, Number 2
<< Back Next >>
Rev Cubana Pediatr 2017; 89 (2)
Open randomized study of children with acute exacerbation of asthma and treated with inhaled steroids
Kassisse E, Prada L, Salazar I, García H, Kassisse J
Language: Spanish
References: 35
Page: 165-176
PDF size: 305.58 Kb.
ABSTRACT
Introduction: primary therapy for acute asthma attacks includes administration of oxygen, use of inhaled β
2-agonists and of systemic steroids. The advantages of the use of inhaled steroids will be rapid onset of action and good safety profile in comparison with the systemic steroids.
Objective: to evaluate the usefulness of inhaled corticoids in treating acute asthma attacks in children older than 2 years.
Methods: prospective, cross-sectional, experimental, randomized study of clinical effectiveness was conducted; the selection of patients was based on a random number table and included three groups: the first received standard treatment, the second one replaced systemic steroid by the inhaled one and the third combined standard treatment and inhaled steroid. The statistical analysis included ANOVA and
Chi-square with p ‹ 0.05 as significant value.
Results: one hundred and sixty five patients were studied and the three treatment groups improved their initial severity scale. The patients who received inhaled steroids added to the standard therapy showed 73 % possibilities of non hospitalization, 27 % possibilities of reduced risk of hospitalization and 8 hospitalizations were prevented per every 100 patients treated with the combination.
Conclusions: inhaled steroids were therapeutically equivalent to systemic steroids.
REFERENCES
Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee Report. Allergy. 2004;59:469-78.
Weiss K, Sullivan S, Lyttle C. Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immuno. 2000;106:493-9.
Roy S, Milgron H. Management of the acute exacerbation of asthma. J Asthma. 2003;40:593-604.
Urso D. Treatment for acute asthma in the Emergency Department: practical aspects. Eur Rev Med Pharmacol Sci. 2010;14(3):209-14.
Powell R. Acute severe asthma. Journal of Paediatrics and Child Health. 2016;52:187-91.
Schuh S, Reisman J, Alshehri M, Dupuis A, Corey M, Arseneault R, et al. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma. N Engl J Med. 2000;343:689-94.
Volovitz B, Bentur I, Finkelstein Y. Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone. J Allergy Clin Immunol. 1998;102:605-9.
Upham B, Mollen C, Scarfone R, Seiden J, Chew A, Zorc J. Nebulized budesonide added to standard pediatric emergency department treatment of acute asthma: a randomized, double-blind trial. Acad Emerg Med. 2011;18:665-73.
Nuhoglu Y, Bahceciler N, Barlan I, Müjdat M. The effectiveness of high-dose inhaled budesonide therapy in the treatment of acute asthma exacerbations in children. Ann Allergy Asthma Immunol. 2001,86:318-22.
Edmonds M, Camargo C, Pollack C, Rowe B. The effectiveness of inhaled corticosteroids in the emergency department treatment of acute asthma: a meta-analysis. Ann Emerg Med. 2002;40:145-50.
Horvath G, Vasas A, Wanner A. Inhaled corticosteroids reduce asthma-associated airway hyperperfusion through genomic and nongenomic mechanisms. Pulm Pharmacol Ther. 2007;20:157-62.
Mendes E, Cadet L, Arana J, Wanner A. Acute effect of an inhaled glucocorticosteroid on albuterol-induced bronchodilation in patients with moderately severe asthma. Chest. 2015;147(4):1037-42.
Volovitz B, Nussinovitch M, Finkelstein Y, Harel L, Varsano I. Effectiveness of inhaled corticosteroids in controlling acute asthma exacerbations in children at home. Clin Pediatr. 2001;40:79-86.
Rodrigo G. Rapid effects of inhaled corticosteroids in acute asthma: an evidence-based evaluation. Chest. 2006;130:1301-11.
Vathenen A, Knox A, Wisniewski A, Tattersfield A. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. Am Rev Respir Dis. 1991;143(6):1317-21.
Hsu P, Lam LT, Browne G. The pulmonary index score as a clinical assessment tool for acute childhood asthma. Ann Allergy Asthma Immunol. 2010;105:425-9.
Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol. 2007;120:S94-S138.
Global strategy for asthma management and prevention. Global Initiative for Asthma (GINA) [homepage en Internet]; GINA, 2016 [citado 28 de Agosto de 2016]. Disponible en: http://ginasthma.org/
Agertoft L, Andersen A, Weibull E, Pedersen S. Systemic availability and pharmacokinetics of nebulised budesonide in preschool children. Arch Dis Child. 1999;80:241-7.
Takeshi K, Kenichi T, Atsushi I, Eiji M, Yutaka U, Toshio K. Usefulness of modified Pulmonary Index Score (mPIS) as a quantitative tool for the evaluation of severe acute exacerbation in asthmatic children. Allergology International. 2015;64:139-44.
Ducharme FM, Chalut D, Plotnick L, Savdie C, Kudirka D, Zhang X. The Pediatric Respiratory Assessment Measure: a valid clinical score for assessing acute asthma severity from toddlers to teenagers. J Pediatr. 2008;152:476-80.
Buyuktiryaki A, Civelek E, Can D, Orhan F, Aydogan M, Reisli I. Predicting hospitalization in children with acute asthma. J Emerg Med. 2013;44:919-27.
Devidayal S, Singhi S, Kumar L, Jayshree M. Efficacy of nebulized budesonide compared to oral prednisolone in acute bronchial asthma. Acta Paediatr. 1999;88:835-40.
Nuhoglu Y, Nuhoglu A. Acute effect of nebulized budesonide in asthmatic children. J Invest Allergol Clin Immunol. 2005;15:197-200.
25.Milani G, Rosário N, Riedi C, Figueiredo B. Nebulized budesonide to treat acute asthma in children. J Pediatr (Rio J). 2004;80:106-12.
McFadden E, Kiser R, DeGroot W. Acute bronchial asthma. Relations between clinical and physiologic manifestations. N Engl J Med. 1973;288:221-5.
Beckhaus A, Riutort M, Castro-Rodriguez JA.Inhaled versus systemic corticosteroids for acute asthma in children. A systematic review. Pediatric Pulmonology. 2014;49:326-34.
Su X, Yu N, Kong L, Kang J. Effectiveness of inhaled corticosteroids in the treatment of acute asthma in children in the emergency department: A meta-analysis. Annals of Medicine. 2014;46:24-30.
Manjra A, Price J, Lenney W, Hughes S, Barnacle H. Efficacy of nebulized fluticasone propionate compared with oral prednisolone in children with an acute exacerbation of asthma. Respir Med. 2000;94:1206-14.
Nakanishi A, Klasner A, Rubin B. A randomized controlled trial of inhaled flunisolide in the management of acute asthma in children. Chest. 2003;124:790-4.
Volovitz B. Inhaled budesonide in the management of acute worsenings and exacerbations of asthma: A review of the evidence. Respir Med. 2007;101:685-95.
Bottaro F. Claves para la interpretación de conceptos estadísticos en estudios de investigación. Hematología. 2013;71:299-305.
Rowe B, Bota G, Fabris L, Therrien S, Milner R, Jacono J. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial. JAMA. 1999;281:2119-26.
Akhtaruzzaman M, Ahmed S, Hoque M, Choudhury A, Hossain M, Islam M, et al. Effects of nebulized budesonide as an adjunct to standard treatment of asthma exacerbations: a randomized, double-blind, placebo-controlled trial. Mymensingh Med J. 2014;23:418-25.
Razi C, Akelma K, Harmanci K, Kocak M, Kuras C. The addition of inhaled budesonideto standard therapy shortens the length of stay in hospital for asthmatic preschool children: A randomized, double-blind, placebo-controlled trial. Int Arch Allergy Immunol. 2015;166:297-303.